Clinical Prospects of NF-kB Inhibitors to Further Targeted Therapies in Rheumatology

Stefan K. Drexler; Jeremy J. O. Turner; Brian M. Foxwell

Clinical Prospects of NF-kB Inhibitors to Further Targeted Therapies in Rheumatology

Stefan K. Drexler, Jeremy J. O. Turner, Brian M. Foxwell

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Many anti-inflammatory drugs currently used in clinical rheumatology are limited by lack of target specificity and a broad range of side effects consequent upon this. Thus, there is much interest in the possibility of developing improved targeted therapies that will have greater clinical efficacy combined with a narrower range of side effects.

Original language	English
Title of host publication	Contemporary Targeted Therapies in Rheumatology
Editors	Peter E. Lipsky, Josef S. Smolen
Publisher	Informa Healthcare
Pages	581-600
Number of pages	20
ISBN (Print)	10: 1841844845
Publication status	Published - 2007

Cite this

@inbook{dad54dbd1efc434a9ccd5347dc0a1e8d,

title = "Clinical Prospects of NF-kB Inhibitors to Further Targeted Therapies in Rheumatology",

abstract = "Many anti-inflammatory drugs currently used in clinical rheumatology are limited by lack of target specificity and a broad range of side effects consequent upon this. Thus, there is much interest in the possibility of developing improved targeted therapies that will have greater clinical efficacy combined with a narrower range of side effects.",

author = "Drexler, {Stefan K.} and Turner, {Jeremy J. O.} and Foxwell, {Brian M.}",

year = "2007",

language = "English",

isbn = "10: 1841844845",

pages = "581--600",

editor = "Lipsky, {Peter E.} and Smolen, {Josef S.}",

booktitle = "Contemporary Targeted Therapies in Rheumatology",

publisher = "Informa Healthcare",

address = "United Kingdom",

}

TY - CHAP

T1 - Clinical Prospects of NF-kB Inhibitors to Further Targeted Therapies in Rheumatology

AU - Drexler, Stefan K.

AU - Turner, Jeremy J. O.

AU - Foxwell, Brian M.

PY - 2007

Y1 - 2007

N2 - Many anti-inflammatory drugs currently used in clinical rheumatology are limited by lack of target specificity and a broad range of side effects consequent upon this. Thus, there is much interest in the possibility of developing improved targeted therapies that will have greater clinical efficacy combined with a narrower range of side effects.

AB - Many anti-inflammatory drugs currently used in clinical rheumatology are limited by lack of target specificity and a broad range of side effects consequent upon this. Thus, there is much interest in the possibility of developing improved targeted therapies that will have greater clinical efficacy combined with a narrower range of side effects.

M3 - Chapter

SN - 10: 1841844845

SP - 581

EP - 600

BT - Contemporary Targeted Therapies in Rheumatology

A2 - Lipsky, Peter E.

A2 - Smolen, Josef S.

PB - Informa Healthcare

ER -